CNXC, US20602D1019

Concentrix stock gains 1.19 percent after Q3 results

Published on 10/05/2026 at 17:24 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Concentrix stock posted Q3 adjusted EPS of USD 2.92 versus USD 2.78 a year earlier on September 29, 2026. Revenue fell 1.2 percent to USD 2,453.7 million.

CNXC, US20602D1019, Illustration mit AI erstellt.

Concentrix Corporation (ISIN US20602D1019) was trading at USD 25.21 on Nasdaq on October 5, 2026 at 11:24 a.m. ET, up 1.19 percent. The company reported fiscal third-quarter results on September 29, with adjusted earnings improving even as a goodwill charge produced a large GAAP loss.

Q3 revenue slips as margins improve

According to Concentrix on September 29, 2026, revenue for the quarter ended August 31, 2026, declined 1.2 percent year over year to USD 2,453.7 million from USD 2,483.3 million.

The quality of earnings was better than the headline loss suggests. Non-GAAP diluted EPS rose 5.0 percent to USD 2.92 from USD 2.78, while non-GAAP operating margin increased to 12.6 percent from 12.3 percent, according to Concentrix.

Goodwill charge shapes the risk picture

GAAP operating loss reached USD 910.3 million in fiscal Q3 2026, compared with operating income of USD 147.0 million a year earlier. The result included a USD 1,050.0 million non-cash goodwill impairment charge tied primarily to the recent trading range for the stock and its market capitalization.

Cash generation provided a counterweight. Operating cash flow reached USD 268.2 million and adjusted free cash flow totaled USD 218.3 million in the quarter, while management guided to fiscal-year adjusted free cash flow of USD 630.0 million to USD 650.0 million.

Analysts see room above the share price

MarketBeat reports a Hold consensus from six analysts, comprising three Buy ratings, two Hold ratings and one Sell rating, with an average price target of USD 33.50. That target lies 32.8 percent above the Nasdaq price of USD 25.21 on October 5, 2026, based on the consensus figures published by MarketBeat.

BofA Securities cut its price target to USD 29.00 from USD 30.00 while retaining a Neutral rating on October 1, 2026, as reported by Investing.com. The contrast between improving adjusted margins and declining revenue leaves top-line stabilization as the central operating test.

Concentrix stock trades above yearly low

Concentrix stock was trading at USD 25.21 on Nasdaq on October 5, 2026 at 11:24 a.m. ET, up USD 0.30 or 1.19 percent from USD 24.91. The session range was USD 24.50 to USD 25.75, while the 52-week range stood at USD 19.12 to USD 49.37 and market capitalization was USD 1.5 billion.